Mehmet Birhan Yilmaz. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Anticholesteremic Agents/administration & dosageAortic Valve Stenosis/complicationsAortic Valve Stenosis/diagnostic imagingAortic Valve Stenosis/drug therapyCholesterol, HDL/bloodCholesterol, HDL/drug effectsCholesterol, LDL/bloodCholesterol, LDL/drug effectsDisease ProgressionDose-Response Relationship, DrugFemaleHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic useHypercholesterolemia/bloodHypercholesterolemia/complicationsHypercholesterolemia/drug therapyMalePrognosisProspective StudiesRadiographyRisk AssessmentSeverity of Illness IndexTreatment Outcome
Substances： See more » Anticholesteremic AgentsCholesterol, HDLCholesterol, LDLHydroxymethylglutaryl-CoA Reductase Inhibitors
Year: 2007 PMID： 17631225 DOI： 10.1016/j.jacc.2007.02.072
Source DB: PubMed Journal: J Am Coll Cardiol ISSN： 0735-1097 Impact factor: 24.094